Is DHT Production by 5Î±-Reductase Friend or Foe in Prostate Cancer?-Reference-Cited by-同舟云学术

Is DHT Production by 5Î±-Reductase Friend or Foe in Prostate Cancer?

Published:2014-09-16 Issue: Volume:4 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Kosaka Takeo,Miyajima Akira,Oya Mototsugu

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference50 articles.

1. Studies on prostatic cancer â€“ I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate;Huggins;Cancer Res,1941

2. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth;Morgentaler;Eur Urol,2009

3. Testosterone and prostate cancer: an historical perspective on a modern myth;Morgentaler;Eur Urol,2006

4. The risks and benefits of 5alpha-reductase inhibitors for prostate-cancer prevention;Theoret;N Engl J Med,2011

5. Chemoprevention of prostate cancer;Walsh;N Engl J Med,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SH‐PRO extract alleviates benign prostatic hyperplasia via ROS ‐mediated activation of PARP /caspase 3 and inhibition of FOXO3a / AR / PSA signaling in vitro and in vivo;Phytotherapy Research;2022-09-19

2. MicroRNA-99b-5p targets mTOR/AR axis, induces autophagy and inhibits prostate cancer cell proliferation;Tumor Biology;2022-07-05

3. Role of single nucleotide polymorphisms of the HSD3B1 gene (rs6203 and rs33937873) in the prediction of prostate cancer risk;Molecular Medicine Reports;2022-07-04

Risk Factors for Prostate Volume Progression After Prostate-Transurethral Resection

;Research and Reports in Urology;2020-05

5. Previous, Current, and Future Pharmacotherapy and Diagnosis of Prostate Cancer—A Comprehensive Review;Diagnostics;2019-10-25